Clinical Trial Update: Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of the insulin glargine/lixisenatide combination (Soliqua) in adults with type 2 diabetes mellitus has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Soliqua

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED